Market: NASD |
Currency: USD
Address: 47 Thorndike Street
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with NovaRock, Adimab, and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Show more
📈 Leap Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
2025-11-12
-
EPS Estimate:
-0.24
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2023 |
- |
$0.100000 |
- |
2023-06-21 |
- |
Stock split |
|
Total Amount for 2023: $0.100000 |
📅 Earnings & EPS History for Leap Therapeutics, Inc.
| Date | Reported EPS |
|---|
| 2025-11-12 (estimated upcoming) | - |
| 2025-08-14 | -0.4 |
| 2025-05-13 | -0.37 |
| 2025-03-26 | -0.37 |
| 2024-11-13 | -0.44 |
| 2024-08-12 | -0.52 |
| 2024-05-13 | -0.51 |
| 2024-03-18 | -0.2 |
| 2023-11-13 | -0.51 |
| 2023-08-14 | -0.91 |
| 2023-05-15 | -3.2 |
| 2023-03-24 | -1 |
| 2022-11-14 | -1.3 |
| 2022-08-12 | -1.5 |
| 2022-05-13 | -0.9 |
| 2022-03-11 | -0.8 |
| 2021-11-12 | -1.4 |
| 2021-08-13 | -1.2 |
| 2021-05-14 | -1.2 |
| 2021-03-12 | -0.9 |
| 2020-11-12 | -0.9 |
| 2020-08-13 | -1.2 |
| 2020-05-14 | -5.5 |
| 2020-03-16 | -3.2 |
| 2019-11-14 | -3.3 |
📰 Related News & Research
No related articles found for "leap therapeutics".
